Search results
Results from the WOW.Com Content Network
A port is more correctly known as a "totally implantable venous access device". They are also commonly referred to as a Portacath or Chemo port. Brand names include Eco Port, Clip-a-Port, SmartPort, Microport, Bardport, PowerPort, Passport, Port-a-Cath, Infuse-a-Port, Medi-Port, and Bioflo.
There are several reasons for the use of central venous access: [2] To get more than one drug at a time; To get continuous infusion chemo (over 24 hours or longer) To get nutrition; To get frequent treatments; To get treatments at home; To get long-term therapy (over many months or even longer)
However, for people who require long-term central venous catheters who are at a higher risk of infection, for example, people with cancer who at are risk of neutropenia due to their chemotherapy treatment or due to the disease, flushing the catheter with a solution containing an antibiotic and heparin may reduce catheter-related infections. [13]
Preventing contamination at the exit site and ensuring that the lumen is flushed frequently is especially important for oncology patients, as they may have become immunocompromised as a result of cytotoxic chemotherapy. Pyrexia (fever) is one of the symptoms of contamination. This symptom and others, including the observance of swelling or ...
TODAY show's Jill Martin was diagnosed with stage 2 breast cancer. She talks about treatment, including chemotherapy and a double mastectomy.
Chemotherapy is the first line treatment, though sometimes cancers with a genetic component, such as Lynch syndrome, do have targeted treatments that work well, Ruggeri says.
A peripherally inserted central catheter (PICC or PICC line), also called a percutaneous indwelling central catheter or longline, [1] is a form of intravenous access that can be used for a prolonged period of time (e.g., for long chemotherapy regimens, extended antibiotic therapy, or total parenteral nutrition) or for administration of substances that should not be done peripherally (e.g ...
Health insurance company interference is rising, an NBC News investigation found. Doctors say the stakes are highest in cancer care, where delays can be the difference between life and death.